Anticoagulation Therapy: A Clinical Practice Guide

✍ Scribed by William E. Dager, Michael Gulseth, Edith A. Nutescu

• Publisher: American Society of Health-System Pharmacists
• Year: 2018
• Tongue: English
• Leaves: 683
• Edition: 2
• Category: Library

✦ Synopsis

Although highly effective in preventing thromboembolic events, the safe management of anticoagulant therapy continues to be a major challenge, requiring constant monitoring and coordinated models of patient-centered care.

Anticoagulation Therapy: A Clinical Practice Guide, Second Edition, helps take the guesswork out of managing these therapies and provides essential recommendations.

New in This Edition:

• Extensive new information on direct oral anticoagulants (DOACs)
• Expanded information on anticoagulant reversal and expanded use of prothrombin complex concentrates
• New chapters on the use of anticoagulants in special patient populations, the use of anticoagulants in patients with mechanical devices, anticoagulation care delivery standards, regulatory issues, and more
• Four new appendices on the effect of DOACs on chemotherapy, nutritional influences, types of central nervous system hemorrhage, and use of anticoagulation in patients with coagulopathies

✦ Table of Contents

Cover
Title page
Copyright
Dedication
Contents
Contributing Editors
Contributors
Preface
Acknowledgments
Abbreviations
Part I. Anticoagulation Medication Management
Ch 1. Introduction to Anticoagulation Management
Ch 2. Warfarin
Ch 3. Unfractionated Heparin
Ch 4. Low Molecular Weight Heparin and Fondaparinux
Ch 5. Parenteral Direct Thrombin Inhibitors
Ch 6. Thrombolytic Considerations When Used with Anticoagulants
Ch 7. Direct Oral Anticoagulants
Ch 8. Anticoagulation Reversal: Part I—Pharmacology of Agents Used for Reversal
Ch 9. Anticoagulation Reversal: Part II—Clinical Application
Ch 10. Transitions in Care—Periprocedural Bridging and Transitions Between Agents
Ch 11. Considerations in Special Populations
Part II. Conditions Requiring Anticoagulation Therapy
Ch 12. Venous Thromboembolism Prevention
Ch 13. Venous Thromboembolism Treatment
Ch 14. Atrial Fibrillation
Ch 15. Acute Coronary Syndromes
Ch 16. Prosthetic Heart Valves
Ch 17. Mechanical Circulatory Support Devices
Ch 18. Heparin-Induced Thrombocytopenia
Ch 19. Pregnancy
Ch 20. Pediatrics
Part III. Practical Measuring, Monitoring, and Coagulation Laboratory
Insights
Ch 21. Coagulation Laboratory Considerations
Ch 22. Thrombophilias
Part IV. Essentials for Practice Success
Ch 23. Models and Standards of Anticoagulation Care Delivery
Ch 24. Regulatory and Practice Resources
Appendixes
Appendix A. Coagulation Cascade
Appendix B. Agents Implicated in Drug-Induced Thromboembolic Diseases
Appendix C. Nutrition Influence on Anticoagulation
Appendix D. Anticoagulants in Management of Ischemic Stroke or Transient Ischemic Attacks
Appendix E. Citrate Anticoagulation
Appendix F. Examples of Available Bleeding Definitions
Appendix G. Types of CNS Hemorrhage
Appendix H. Disseminated Intravascular Coagulation
Appendix I. Nondrug Causes of Thrombocytopenia
Appendix J. Drug-Related Causes of Thrombocytopenia
Appendix K. Examples of Transfusion-Related Reactions
Appendix L. Considerations for Transitioning from aPTT to Anti-Xa to Manage Heparin Therapy
Appendix M. PIONEER AF-PCI
Appendix N. Betrixaban APEX Trial
Index